<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39340013</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>28</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>Advances in Dendritic-Cell-Based Vaccines against Respiratory Fungal Infections.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">981</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines12090981</ELocationID><Abstract><AbstractText>Ever since the discovery of dendritic cells by Ralph Steinman and Zanvil Cohn in 1973, it is increasingly evident that dendritic cells are integral for adaptive immune responses, and there is an undeniable focus on them for vaccines development. Fungal infections, often thought to be innocuous, are becoming significant threats due to an increased immunocompromised or immune-suppressed population and climate change. Further, the recent COVID-19 pandemic unraveled the wrath of fungal infections and devastating outcomes. Invasive fungal infections cause significant case fatality rates ranging from 20% to 90%. Regrettably, no licensed fungal vaccines exist, and there is an urgent need for preventive and therapeutic purposes. In this review, we discuss the ontogeny, subsets, tissue distribution, and functions of lung dendritic cells. In the latter part, we summarize and discuss the studies on the DC-based vaccines against pulmonary fungal infections. Finally, we highlight some emerging potential avenues that can be incorporated for DC-based vaccines against fungal infections.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kulkarni</LastName><ForeName>Nitish A</ForeName><Initials>NA</Initials><Identifier Source="ORCID">0000-0002-6132-977X</Identifier><AffiliationInfo><Affiliation>Department of Pathobiology, College of Veterinary Medicine, University of Illinois Urbana-Champaign, Urbana, IL 61802, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nanjappa</LastName><ForeName>Som G</ForeName><Initials>SG</Initials><Identifier Source="ORCID">0000-0001-8022-1353</Identifier><AffiliationInfo><Affiliation>Department of Pathobiology, College of Veterinary Medicine, University of Illinois Urbana-Champaign, Urbana, IL 61802, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01AI153522</GrantID><Agency>NIH-NIAID</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DC-based vaccine</Keyword><Keyword MajorTopicYN="N">adaptive immune response</Keyword><Keyword MajorTopicYN="N">dendritic cells</Keyword><Keyword MajorTopicYN="N">pulmonary fungal infections</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of the data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39340013</ArticleId><ArticleId IdType="pmc">PMC11435842</ArticleId><ArticleId IdType="doi">10.3390/vaccines12090981</ArticleId><ArticleId IdType="pii">vaccines12090981</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Denning D.W. Global incidence and mortality of severe fungal disease. Lancet Infect. Dis. 2024;24:e428–e438. doi: 10.1016/S1473-3099(23)00692-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00692-8</ArticleId><ArticleId IdType="pubmed">38224705</ArticleId></ArticleIdList></Reference><Reference><Citation>Bongomin F., Gago S., Oladele R.O., Denning D.W. Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision. J. Fungi. 2017;3:57. doi: 10.3390/jof3040057.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jof3040057</ArticleId><ArticleId IdType="pmc">PMC5753159</ArticleId><ArticleId IdType="pubmed">29371573</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedict K., Whitham H.K., Jackson B.R. Economic Burden of Fungal Diseases in the United States. Open Forum Infect. Dis. 2022;9:ofac097. doi: 10.1093/ofid/ofac097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac097</ArticleId><ArticleId IdType="pmc">PMC8946773</ArticleId><ArticleId IdType="pubmed">35350173</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention  Data and Statistics on Fungal Diseases.  [(accessed on 8 July 2024)]; Available online:  https://www.cdc.gov/fungal/data-research/facts-stats/index.html.</Citation></Reference><Reference><Citation>Robbins N., Wright G.D., Cowen L.E. Antifungal Drugs: The Current Armamentarium and Development of New Agents. Microbiol. Spectr. 2016;4:FUNK-0002-2016. doi: 10.1128/microbiolspec.FUNK-0002-2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/microbiolspec.FUNK-0002-2016</ArticleId><ArticleId IdType="pubmed">27763259</ArticleId></ArticleIdList></Reference><Reference><Citation>Srinivasan A., Lopez-Ribot J.L., Ramasubramanian A.K. Overcoming antifungal resistance. Drug Discov. Today Technol. 2014;11:65–71. doi: 10.1016/j.ddtec.2014.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ddtec.2014.02.005</ArticleId><ArticleId IdType="pmc">PMC4031462</ArticleId><ArticleId IdType="pubmed">24847655</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas C.M., Shae W., Koestler D., DeFor T., Bahr N.C., Alpern J.D. Antifungal drug price increases in the United States, 2000–2019. Mycoses. 2022;65:859–865. doi: 10.1111/myc.13486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/myc.13486</ArticleId><ArticleId IdType="pmc">PMC9378588</ArticleId><ArticleId IdType="pubmed">35722703</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinman R.M., Cohn Z.A. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med. 1973;137:1142–1162. doi: 10.1084/jem.137.5.1142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.137.5.1142</ArticleId><ArticleId IdType="pmc">PMC2139237</ArticleId><ArticleId IdType="pubmed">4573839</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinman R.M. Dendritic cells and the control of immunity: Enhancing the efficiency of antigen presentation. Mt. Sinai J. Med. 2001;68:160–166.</Citation><ArticleIdList><ArticleId IdType="pubmed">11373688</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilliams M., Lambrecht B.N., Hammad H. Division of labor between lung dendritic cells and macrophages in the defense against pulmonary infections. Mucosal Immunol. 2013;6:464–473. doi: 10.1038/mi.2013.14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2013.14</ArticleId><ArticleId IdType="pubmed">23549447</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosteels C., Neyt K., Vanheerswynghels M., van Helden M.J., Sichien D., Debeuf N., De Prijck S., Bosteels V., Vandamme N., Martens L., et al. Inflammatory Type 2 cDCs Acquire Features of cDC1s and Macrophages to Orchestrate Immunity to Respiratory Virus Infection. Immunity. 2020;52:1039–1056.E9. doi: 10.1016/j.immuni.2020.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.04.005</ArticleId><ArticleId IdType="pmc">PMC7207120</ArticleId><ArticleId IdType="pubmed">32392463</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawasaki T., Ikegawa M., Kawai T. Antigen Presentation in the Lung. Front. Immunol. 2022;13:860915. doi: 10.3389/fimmu.2022.860915.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.860915</ArticleId><ArticleId IdType="pmc">PMC9124800</ArticleId><ArticleId IdType="pubmed">35615351</ArticleId></ArticleIdList></Reference><Reference><Citation>Kischkel B., Rossi S.A., Santos S.R., Nosanchuk J.D., Travassos L.R., Taborda C.P. Therapies and Vaccines Based on Nanoparticles for the Treatment of Systemic Fungal Infections. Front. Cell Infect. Microbiol. 2020;10:463. doi: 10.3389/fcimb.2020.00463.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.00463</ArticleId><ArticleId IdType="pmc">PMC7502903</ArticleId><ArticleId IdType="pubmed">33014889</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzo J., Rodrigues M.L., Janbon G. Extracellular Vesicles in Fungi: Past, Present, and Future Perspectives. Front. Cell Infect. Microbiol. 2020;10:346. doi: 10.3389/fcimb.2020.00346.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.00346</ArticleId><ArticleId IdType="pmc">PMC7373726</ArticleId><ArticleId IdType="pubmed">32760680</ArticleId></ArticleIdList></Reference><Reference><Citation>Mack S.M., Madl A.K., Pinkerton K.E. Respiratory Health Effects of Exposure to Ambient Particulate Matter and Bioaerosols. Compr. Physiol. 2019;10:1–20. doi: 10.1002/cphy.c180040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cphy.c180040</ArticleId><ArticleId IdType="pmc">PMC7553137</ArticleId><ArticleId IdType="pubmed">31853953</ArticleId></ArticleIdList></Reference><Reference><Citation>von Garnier C., Filgueira L., Wikstrom M., Smith M., Thomas J.A., Strickland D.H., Holt P.G., Stumbles P.A. Anatomical location determines the distribution and function of dendritic cells and other APCs in the respiratory tract. J. Immunol. 2005;175:1609–1618. doi: 10.4049/jimmunol.175.3.1609.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.175.3.1609</ArticleId><ArticleId IdType="pubmed">16034100</ArticleId></ArticleIdList></Reference><Reference><Citation>Condon T.V., Sawyer R.T., Fenton M.J., Riches D.W. Lung dendritic cells at the innate-adaptive immune interface. J. Leukoc. Biol. 2011;90:883–895. doi: 10.1189/jlb.0311134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0311134</ArticleId><ArticleId IdType="pmc">PMC3206474</ArticleId><ArticleId IdType="pubmed">21807741</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang J.Y., Randall T.D., Silva-Sanchez A. Inducible Bronchus-Associated Lymphoid Tissue: Taming Inflammation in the Lung. Front. Immunol. 2016;7:258. doi: 10.3389/fimmu.2016.00258.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2016.00258</ArticleId><ArticleId IdType="pmc">PMC4928648</ArticleId><ArticleId IdType="pubmed">27446088</ArticleId></ArticleIdList></Reference><Reference><Citation>Lysen A., Gudjonsson A., Tesfaye D.Y., Bobic S., Bern M., Bogen B., Fossum E. Intranasal delivery of a cDC1 targeted influenza vaccine with poly(I:C) enhances T cell responses and protects against influenza infection. Scand. J. Immunol. 2022;95:e13128. doi: 10.1111/sji.13128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sji.13128</ArticleId><ArticleId IdType="pubmed">34923667</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilliams M., Henri S., Tamoutounour S., Ardouin L., Schwartz-Cornil I., Dalod M., Malissen B. From skin dendritic cells to a simplified classification of human and mouse dendritic cell subsets. Eur. J. Immunol. 2010;40:2089–2094. doi: 10.1002/eji.201040498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201040498</ArticleId><ArticleId IdType="pubmed">20853491</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachem A., Guttler S., Hartung E., Ebstein F., Schaefer M., Tannert A., Salama A., Movassaghi K., Opitz C., Mages H.W., et al. Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells. J. Exp. Med. 2010;207:1273–1281. doi: 10.1084/jem.20100348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20100348</ArticleId><ArticleId IdType="pmc">PMC2882837</ArticleId><ArticleId IdType="pubmed">20479115</ArticleId></ArticleIdList></Reference><Reference><Citation>Desch A.N., Randolph G.J., Murphy K., Gautier E.L., Kedl R.M., Lahoud M.H., Caminschi I., Shortman K., Henson P.M., Jakubzick C.V. CD103+ pulmonary dendritic cells preferentially acquire and present apoptotic cell-associated antigen. J. Exp. Med. 2011;208:1789–1797. doi: 10.1084/jem.20110538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20110538</ArticleId><ArticleId IdType="pmc">PMC3171085</ArticleId><ArticleId IdType="pubmed">21859845</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber A., Dammeijer F., Aerts J., Vroman H. Current State of Dendritic Cell-Based Immunotherapy: Opportunities for in vitro Antigen Loading of Different DC Subsets? Front. Immunol. 2018;9:2804. doi: 10.3389/fimmu.2018.02804.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02804</ArticleId><ArticleId IdType="pmc">PMC6287551</ArticleId><ArticleId IdType="pubmed">30559743</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz F.M., Chan A., Rock K.L. Pathways of MHC I cross-presentation of exogenous antigens. Semin. Immunol. 2023;66:101729. doi: 10.1016/j.smim.2023.101729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2023.101729</ArticleId><ArticleId IdType="pmc">PMC10023513</ArticleId><ArticleId IdType="pubmed">36804685</ArticleId></ArticleIdList></Reference><Reference><Citation>Raymond M., Rubio M., Fortin G., Shalaby K.H., Hammad H., Lambrecht B.N., Sarfati M. Selective control of SIRP-alpha-positive airway dendritic cell trafficking through CD47 is critical for the development of TH2-mediated allergic inflammation. J. Allergy Clin. Immunol. 2009;124:1333–1342.E1. doi: 10.1016/j.jaci.2009.07.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2009.07.021</ArticleId><ArticleId IdType="pubmed">19748659</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammad H., Lambrecht B.N. Dendritic cells and epithelial cells: Linking innate and adaptive immunity in asthma. Nat. Rev. Immunol. 2008;8:193–204. doi: 10.1038/nri2275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2275</ArticleId><ArticleId IdType="pubmed">18301423</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy R.M., Klein B.S. Dendritic cells in antifungal immunity and vaccine design. Cell Host Microbe. 2012;11:436–446. doi: 10.1016/j.chom.2012.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2012.04.005</ArticleId><ArticleId IdType="pmc">PMC3401965</ArticleId><ArticleId IdType="pubmed">22607797</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardner A., Ruffell B. moDCs, Less Problems. Immunity. 2018;48:6–8. doi: 10.1016/j.immuni.2017.12.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2017.12.017</ArticleId><ArticleId IdType="pubmed">29343441</ArticleId></ArticleIdList></Reference><Reference><Citation>Banki Z., Werner R., Riepler L., Rossler A., Mullauer B., Hegen V., Bayer W., Verbeek J.S., Dittmer U., Stoiber H. Fcgamma Receptor Type I (CD64)-Mediated Impairment of the Capacity of Dendritic Cells to Activate Specific CD8 T Cells by IgG-opsonized Friend Virus. Viruses. 2019;11:145. doi: 10.3390/v11020145.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11020145</ArticleId><ArticleId IdType="pmc">PMC6410291</ArticleId><ArticleId IdType="pubmed">30744065</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamoutounour S., Henri S., Lelouard H., de Bovis B., de Haar C., van der Woude C.J., Woltman A.M., Reyal Y., Bonnet D., Sichien D., et al. CD64 distinguishes macrophages from dendritic cells in the gut and reveals the Th1-inducing role of mesenteric lymph node macrophages during colitis. Eur. J. Immunol. 2012;42:3150–3166. doi: 10.1002/eji.201242847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201242847</ArticleId><ArticleId IdType="pubmed">22936024</ArticleId></ArticleIdList></Reference><Reference><Citation>Langlet C., Tamoutounour S., Henri S., Luche H., Ardouin L., Gregoire C., Malissen B., Guilliams M. CD64 expression distinguishes monocyte-derived and conventional dendritic cells and reveals their distinct role during intramuscular immunization. J. Immunol. 2012;188:1751–1760. doi: 10.4049/jimmunol.1102744.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1102744</ArticleId><ArticleId IdType="pubmed">22262658</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheong C., Matos I., Choi J.H., Dandamudi D.B., Shrestha E., Longhi M.P., Jeffrey K.L., Anthony R.M., Kluger C., Nchinda G., et al. Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas. Cell. 2010;143:416–429. doi: 10.1016/j.cell.2010.09.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.09.039</ArticleId><ArticleId IdType="pmc">PMC3150728</ArticleId><ArticleId IdType="pubmed">21029863</ArticleId></ArticleIdList></Reference><Reference><Citation>Leon B., Lopez-Bravo M., Ardavin C. Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity. 2007;26:519–531. doi: 10.1016/j.immuni.2007.01.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2007.01.017</ArticleId><ArticleId IdType="pubmed">17412618</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X., Briseno C.G., Durai V., Albring J.C., Haldar M., Bagadia P., Kim K.W., Randolph G.J., Murphy T.L., Murphy K.M. Mafb lineage tracing to distinguish macrophages from other immune lineages reveals dual identity of Langerhans cells. J. Exp. Med. 2016;213:2553–2565. doi: 10.1084/jem.20160600.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20160600</ArticleId><ArticleId IdType="pmc">PMC5110021</ArticleId><ArticleId IdType="pubmed">27810926</ArticleId></ArticleIdList></Reference><Reference><Citation>Backer R.A., Probst H.C., Clausen B.E. Classical DC2 subsets and monocyte-derived DC: Delineating the developmental and functional relationship. Eur. J. Immunol. 2023;53:e2149548. doi: 10.1002/eji.202149548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.202149548</ArticleId><ArticleId IdType="pubmed">36642930</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautier E.L., Shay T., Miller J., Greter M., Jakubzick C., Ivanov S., Helft J., Chow A., Elpek K.G., Gordonov S., et al. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat. Immunol. 2012;13:1118–1128. doi: 10.1038/ni.2419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2419</ArticleId><ArticleId IdType="pmc">PMC3558276</ArticleId><ArticleId IdType="pubmed">23023392</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu K., Victora G.D., Schwickert T.A., Guermonprez P., Meredith M.M., Yao K., Chu F.F., Randolph G.J., Rudensky A.Y., Nussenzweig M. In vivo analysis of dendritic cell development and homeostasis. Science. 2009;324:392–397. doi: 10.1126/science.1170540.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1170540</ArticleId><ArticleId IdType="pmc">PMC2803315</ArticleId><ArticleId IdType="pubmed">19286519</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopf M., Schneider C., Nobs S.P. The development and function of lung-resident macrophages and dendritic cells. Nat. Immunol. 2015;16:36–44. doi: 10.1038/ni.3052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3052</ArticleId><ArticleId IdType="pubmed">25521683</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel V.I., Booth J.L., Duggan E.S., Cate S., White V.L., Hutchings D., Kovats S., Burian D.M., Dozmorov M., Metcalf J.P. Transcriptional Classification and Functional Characterization of Human Airway Macrophage and Dendritic Cell Subsets. J. Immunol. 2017;198:1183–1201. doi: 10.4049/jimmunol.1600777.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1600777</ArticleId><ArticleId IdType="pmc">PMC5262539</ArticleId><ArticleId IdType="pubmed">28031342</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson D.A., III, Dutertre C.A., Ginhoux F., Murphy K.M. Genetic models of human and mouse dendritic cell development and function. Nat. Rev. Immunol. 2021;21:101–115. doi: 10.1038/s41577-020-00413-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-00413-x</ArticleId><ArticleId IdType="pmc">PMC10955724</ArticleId><ArticleId IdType="pubmed">32908299</ArticleId></ArticleIdList></Reference><Reference><Citation>Diao J., Winter E., Cantin C., Chen W., Xu L., Kelvin D., Phillips J., Cattral M.S. In situ replication of immediate dendritic cell (DC) precursors contributes to conventional DC homeostasis in lymphoid tissue. J. Immunol. 2006;176:7196–7206. doi: 10.4049/jimmunol.176.12.7196.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.176.12.7196</ArticleId><ArticleId IdType="pubmed">16751363</ArticleId></ArticleIdList></Reference><Reference><Citation>Maraskovsky E., Brasel K., Teepe M., Roux E.R., Lyman S.D., Shortman K., McKenna H.J. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: Multiple dendritic cell subpopulations identified. J. Exp. Med. 1996;184:1953–1962. doi: 10.1084/jem.184.5.1953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.184.5.1953</ArticleId><ArticleId IdType="pmc">PMC2192888</ArticleId><ArticleId IdType="pubmed">8920882</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisenbarth S.C. Dendritic cell subsets in T cell programming: Location dictates function. Nat. Rev. Immunol. 2019;19:89–103. doi: 10.1038/s41577-018-0088-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-018-0088-1</ArticleId><ArticleId IdType="pmc">PMC7755085</ArticleId><ArticleId IdType="pubmed">30464294</ArticleId></ArticleIdList></Reference><Reference><Citation>Schraml B.U., van Blijswijk J., Zelenay S., Whitney P.G., Filby A., Acton S.E., Rogers N.C., Moncaut N., Carvajal J.J., Reis e Sousa C. Genetic tracing via DNGR-1 expression history defines dendritic cells as a hematopoietic lineage. Cell. 2013;154:843–858. doi: 10.1016/j.cell.2013.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.07.014</ArticleId><ArticleId IdType="pubmed">23953115</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilliet M., Boonstra A., Paturel C., Antonenko S., Xu X.L., Trinchieri G., O’Garra A., Liu Y.J. The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 2002;195:953–958. doi: 10.1084/jem.20020045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20020045</ArticleId><ArticleId IdType="pmc">PMC2193725</ArticleId><ArticleId IdType="pubmed">11927638</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams N.M., Das A., Yun T.J., Reizis B. Ontogeny and Function of Plasmacytoid Dendritic Cells. Annu. Rev. Immunol. 2024;42:347–373. doi: 10.1146/annurev-immunol-090122-041105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-090122-041105</ArticleId><ArticleId IdType="pubmed">38941603</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds G., Tirard A., Villani A.C. Plasmacytoid dendritic cells: Welcome back to the DC fold. Immunity. 2022;55:380–382. doi: 10.1016/j.immuni.2022.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.02.011</ArticleId><ArticleId IdType="pubmed">35263562</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler-Heitbrock L., Ohteki T., Ginhoux F., Shortman K., Spits H. Reclassification of plasmacytoid dendritic cells as innate lymphocytes is premature. Nat. Rev. Immunol. 2023;23:338–339. doi: 10.1038/s41577-023-00866-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-023-00866-w</ArticleId><ArticleId IdType="pubmed">36959480</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagasawa M., Schmidlin H., Hazekamp M.G., Schotte R., Blom B. Development of human plasmacytoid dendritic cells depends on the combined action of the basic helix-loop-helix factor E2-2 and the Ets factor Spi-B. Eur. J. Immunol. 2008;38:2389–2400. doi: 10.1002/eji.200838470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.200838470</ArticleId><ArticleId IdType="pubmed">18792017</ArticleId></ArticleIdList></Reference><Reference><Citation>Cisse B., Caton M.L., Lehner M., Maeda T., Scheu S., Locksley R., Holmberg D., Zweier C., den Hollander N.S., Kant S.G., et al. Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell. 2008;135:37–48. doi: 10.1016/j.cell.2008.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2008.09.016</ArticleId><ArticleId IdType="pmc">PMC2631034</ArticleId><ArticleId IdType="pubmed">18854153</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M., Sathe P., Helft J., Miller J., Mortha A. The dendritic cell lineage: Ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu. Rev. Immunol. 2013;31:563–604. doi: 10.1146/annurev-immunol-020711-074950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-020711-074950</ArticleId><ArticleId IdType="pmc">PMC3853342</ArticleId><ArticleId IdType="pubmed">23516985</ArticleId></ArticleIdList></Reference><Reference><Citation>Holt P.G., Haining S., Nelson D.J., Sedgwick J.D. Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airways. J. Immunol. 1994;153:256–261. doi: 10.4049/jimmunol.153.1.256.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.153.1.256</ArticleId><ArticleId IdType="pubmed">8207240</ArticleId></ArticleIdList></Reference><Reference><Citation>Ginhoux F., Liu K., Helft J., Bogunovic M., Greter M., Hashimoto D., Price J., Yin N., Bromberg J., Lira S.A., et al. The origin and development of nonlymphoid tissue CD103+ DCs. J. Exp. Med. 2009;206:3115–3130. doi: 10.1084/jem.20091756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20091756</ArticleId><ArticleId IdType="pmc">PMC2806447</ArticleId><ArticleId IdType="pubmed">20008528</ArticleId></ArticleIdList></Reference><Reference><Citation>Segura E., Villadangos J.A. Antigen presentation by dendritic cells in vivo. Curr. Opin. Immunol. 2009;21:105–110. doi: 10.1016/j.coi.2009.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2009.03.011</ArticleId><ArticleId IdType="pubmed">19342210</ArticleId></ArticleIdList></Reference><Reference><Citation>McGinnis M.R., Tyring S.K. Introduction to Mycology. In: Baron S., editor. Medical Microbiology. 4th ed. The University of Texas Medical Branch at Galveston; Galveston, TX, USA: 1996.</Citation><ArticleIdList><ArticleId IdType="pubmed">21413300</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozza S., Gaziano R., Spreca A., Bacci A., Montagnoli C., di Francesco P., Romani L. Dendritic cells transport conidia and hyphae of Aspergillus fumigatus from the airways to the draining lymph nodes and initiate disparate Th responses to the fungus. J. Immunol. 2002;168:1362–1371. doi: 10.4049/jimmunol.168.3.1362.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.168.3.1362</ArticleId><ArticleId IdType="pubmed">11801677</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabeza-Cabrerizo M., Cardoso A., Minutti C.M., Pereira da Costa M., Reis e Sousa C. Dendritic Cells Revisited. Annu. Rev. Immunol. 2021;39:131–166. doi: 10.1146/annurev-immunol-061020-053707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-061020-053707</ArticleId><ArticleId IdType="pubmed">33481643</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller S.N. Spreading the load: Antigen transfer between migratory and lymph node-resident dendritic cells promotes T-cell priming. Eur. J. Immunol. 2017;47:1798–1801. doi: 10.1002/eji.201747248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201747248</ArticleId><ArticleId IdType="pubmed">28845904</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J., Hissong R., Bareis R., Creech A., Goughenour K.D., Freeman C.M., Olszewski M.A. Batf3-dependent orchestration of the robust Th1 responses and fungal control during cryptococcal infection, the role of cDC1. mBio. 2024;15:e0285323. doi: 10.1128/mbio.02853-23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.02853-23</ArticleId><ArticleId IdType="pmc">PMC10936214</ArticleId><ArticleId IdType="pubmed">38349130</ArticleId></ArticleIdList></Reference><Reference><Citation>Guasconi L., Beccacece I., Volpini X., Burstein V.L., Mena C.J., Silvane L., Almeida M.A., Musri M.M., Cervi L., Chiapello L.S. Pulmonary Conventional Type 1 Langerin-Expressing Dendritic Cells Play a Role in Impairing Early Protective Immune Response against Cryptococcus neoformans Infection in Mice. J. Fungi. 2022;8:792. doi: 10.3390/jof8080792.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jof8080792</ArticleId><ArticleId IdType="pmc">PMC9410147</ArticleId><ArticleId IdType="pubmed">36012781</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Prooyen N., Henderson C.A., Hocking Murray D., Sil A. CD103+ Conventional Dendritic Cells Are Critical for TLR7/9-Dependent Host Defense against Histoplasma capsulatum, an Endemic Fungal Pathogen of Humans. PLoS Pathog. 2016;12:e1005749. doi: 10.1371/journal.ppat.1005749.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005749</ArticleId><ArticleId IdType="pmc">PMC4961300</ArticleId><ArticleId IdType="pubmed">27459510</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiesner D.L., Specht C.A., Lee C.K., Smith K.D., Mukaremera L., Lee S.T., Lee C.G., Elias J.A., Nielsen J.N., Boulware D.R., et al. Chitin recognition via chitotriosidase promotes pathologic type-2 helper T cell responses to cryptococcal infection. PLoS Pathog. 2015;11:e1004701. doi: 10.1371/journal.ppat.1004701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004701</ArticleId><ArticleId IdType="pmc">PMC4357429</ArticleId><ArticleId IdType="pubmed">25764512</ArticleId></ArticleIdList></Reference><Reference><Citation>Osterholzer J.J., Curtis J.L., Polak T., Ames T., Chen G.H., McDonald R., Huffnagle G.B., Toews G.B. CCR2 mediates conventional dendritic cell recruitment and the formation of bronchovascular mononuclear cell infiltrates in the lungs of mice infected with Cryptococcus neoformans. J. Immunol. 2008;181:610–620. doi: 10.4049/jimmunol.181.1.610.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.181.1.610</ArticleId><ArticleId IdType="pmc">PMC2735104</ArticleId><ArticleId IdType="pubmed">18566428</ArticleId></ArticleIdList></Reference><Reference><Citation>Ersland K., Wuthrich M., Klein B.S. Dynamic interplay among monocyte-derived, dermal, and resident lymph node dendritic cells during the generation of vaccine immunity to fungi. Cell Host Microbe. 2010;7:474–487. doi: 10.1016/j.chom.2010.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2010.05.010</ArticleId><ArticleId IdType="pmc">PMC2896205</ArticleId><ArticleId IdType="pubmed">20542251</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y., Kasahara S., Jhingran A., Tosini N.L., Zhai B., Aufiero M.A., Mills K.A.M., Gjonbalaj M., Espinosa V., Rivera A., et al. During Aspergillus Infection, Monocyte-Derived DCs, Neutrophils, and Plasmacytoid DCs Enhance Innate Immune Defense through CXCR3-Dependent Crosstalk. Cell Host Microbe. 2020;28:104–116.E4. doi: 10.1016/j.chom.2020.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.05.002</ArticleId><ArticleId IdType="pmc">PMC7263227</ArticleId><ArticleId IdType="pubmed">32485165</ArticleId></ArticleIdList></Reference><Reference><Citation>Trautwein-Weidner K., Gladiator A., Kirchner F.R., Becattini S., Rulicke T., Sallusto F., LeibundGut-Landmann S. Antigen-Specific Th17 Cells Are Primed by Distinct and Complementary Dendritic Cell Subsets in Oropharyngeal Candidiasis. PLoS Pathog. 2015;11:e1005164. doi: 10.1371/journal.ppat.1005164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005164</ArticleId><ArticleId IdType="pmc">PMC4591991</ArticleId><ArticleId IdType="pubmed">26431538</ArticleId></ArticleIdList></Reference><Reference><Citation>Teitz-Tennenbaum S., Viglianti S.P., Roussey J.A., Levitz S.M., Olszewski M.A., Osterholzer J.J. Autocrine IL-10 Signaling Promotes Dendritic Cell Type-2 Activation and Persistence of Murine Cryptococcal Lung Infection. J. Immunol. 2018;201:2004–2015. doi: 10.4049/jimmunol.1800070.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1800070</ArticleId><ArticleId IdType="pmc">PMC6145088</ArticleId><ArticleId IdType="pubmed">30097531</ArticleId></ArticleIdList></Reference><Reference><Citation>Fei M., Bhatia S., Oriss T.B., Yarlagadda M., Khare A., Akira S., Saijo S., Iwakura Y., Fallert Junecko B.A., Reinhart T.A., et al. TNF-alpha from inflammatory dendritic cells (DCs) regulates lung IL-17A/IL-5 levels and neutrophilia versus eosinophilia during persistent fungal infection. Proc. Natl. Acad. Sci. USA. 2011;108:5360–5365. doi: 10.1073/pnas.1015476108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1015476108</ArticleId><ArticleId IdType="pmc">PMC3069210</ArticleId><ArticleId IdType="pubmed">21402950</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S., Deepe G.S., Jr. Notch regulates Histoplasma capsulatum clearance in mouse lungs during innate and adaptive immune response phases in primary infection. J. Leukoc. Biol. 2022;112:1137–1154. doi: 10.1002/JLB.4A1221-743R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.4A1221-743R</ArticleId><ArticleId IdType="pmc">PMC9613517</ArticleId><ArticleId IdType="pubmed">35603470</ArticleId></ArticleIdList></Reference><Reference><Citation>Bacci A., Montagnoli C., Perruccio K., Bozza S., Gaziano R., Pitzurra L., Velardi A., d’Ostiani C.F., Cutler J.E., Romani L. Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation. J. Immunol. 2002;168:2904–2913. doi: 10.4049/jimmunol.168.6.2904.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.168.6.2904</ArticleId><ArticleId IdType="pubmed">11884461</ArticleId></ArticleIdList></Reference><Reference><Citation>Montagnoli C., Bacci A., Bozza S., Gaziano R., Fiorucci S., Spreca A., Romani L. The plasticity of dendritic cells at the host/fungal interface. Immunobiology. 2001;204:582–589. doi: 10.1078/0171-2985-00095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1078/0171-2985-00095</ArticleId><ArticleId IdType="pubmed">11846221</ArticleId></ArticleIdList></Reference><Reference><Citation>d’Ostiani C.F., Del Sero G., Bacci A., Montagnoli C., Spreca A., Mencacci A., Ricciardi-Castagnoli P., Romani L. Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J. Exp. Med. 2000;191:1661–1673. doi: 10.1084/jem.191.10.1661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.191.10.1661</ArticleId><ArticleId IdType="pmc">PMC2193147</ArticleId><ArticleId IdType="pubmed">10811860</ArticleId></ArticleIdList></Reference><Reference><Citation>Mezger M., Kneitz S., Wozniok I., Kurzai O., Einsele H., Loeffler J. Proinflammatory response of immature human dendritic cells is mediated by dectin-1 after exposure to Aspergillus fumigatus germ tubes. J. Infect. Dis. 2008;197:924–931. doi: 10.1086/528694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/528694</ArticleId><ArticleId IdType="pubmed">18279049</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera A., Hohl T.M., Collins N., Leiner I., Gallegos A., Saijo S., Coward J.W., Iwakura Y., Pamer E.G. Dectin-1 diversifies Aspergillus fumigatus-specific T cell responses by inhibiting T helper type 1 CD4 T cell differentiation. J. Exp. Med. 2011;208:369–381. doi: 10.1084/jem.20100906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20100906</ArticleId><ArticleId IdType="pmc">PMC3039849</ArticleId><ArticleId IdType="pubmed">21242294</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephen-Victor E., Karnam A., Fontaine T., Beauvais A., Das M., Hegde P., Prakhar P., Holla S., Balaji K.N., Kaveri S.V., et al. Aspergillus fumigatus Cell Wall alpha-(1,3)-Glucan Stimulates Regulatory T-Cell Polarization by Inducing PD-L1 Expression on Human Dendritic Cells. J. Infect. Dis. 2017;216:1281–1294. doi: 10.1093/infdis/jix469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jix469</ArticleId><ArticleId IdType="pubmed">28968869</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera A., Van Epps H.L., Hohl T.M., Rizzuto G., Pamer E.G. Distinct CD4+-T-cell responses to live and heat-inactivated Aspergillus fumigatus conidia. Infect. Immun. 2005;73:7170–7179. doi: 10.1128/IAI.73.11.7170-7179.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.73.11.7170-7179.2005</ArticleId><ArticleId IdType="pmc">PMC1273880</ArticleId><ArticleId IdType="pubmed">16239511</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohl T.M., Van Epps H.L., Rivera A., Morgan L.A., Chen P.L., Feldmesser M., Pamer E.G. Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display. PLoS Pathog. 2005;1:e30. doi: 10.1371/journal.ppat.0010030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.0010030</ArticleId><ArticleId IdType="pmc">PMC1287910</ArticleId><ArticleId IdType="pubmed">16304610</ArticleId></ArticleIdList></Reference><Reference><Citation>Heung L.J., Wiesner D.L., Wang K., Rivera A., Hohl T.M. Immunity to fungi in the lung. Semin. Immunol. 2023;66:101728. doi: 10.1016/j.smim.2023.101728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2023.101728</ArticleId><ArticleId IdType="pmc">PMC10148604</ArticleId><ArticleId IdType="pubmed">36841146</ArticleId></ArticleIdList></Reference><Reference><Citation>Salazar F., Brown G.D. Antifungal Innate Immunity: A Perspective from the Last 10 Years. J. Innate Immun. 2018;10:373–397. doi: 10.1159/000488539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000488539</ArticleId><ArticleId IdType="pmc">PMC6784043</ArticleId><ArticleId IdType="pubmed">29768268</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez-Ortiz Z.G., Lee C.K., Wang J.P., Boon L., Specht C.A., Levitz S.M. A nonredundant role for plasmacytoid dendritic cells in host defense against the human fungal pathogen Aspergillus fumigatus. Cell Host Microbe. 2011;9:415–424. doi: 10.1016/j.chom.2011.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2011.04.007</ArticleId><ArticleId IdType="pmc">PMC3100664</ArticleId><ArticleId IdType="pubmed">21575912</ArticleId></ArticleIdList></Reference><Reference><Citation>Loures F.V., Rohm M., Lee C.K., Santos E., Wang J.P., Specht C.A., Calich V.L., Urban C.F., Levitz S.M. Recognition of Aspergillus fumigatus hyphae by human plasmacytoid dendritic cells is mediated by dectin-2 and results in formation of extracellular traps. PLoS Pathog. 2015;11:e1004643. doi: 10.1371/journal.ppat.1004643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004643</ArticleId><ArticleId IdType="pmc">PMC4450068</ArticleId><ArticleId IdType="pubmed">25659141</ArticleId></ArticleIdList></Reference><Reference><Citation>Araujo E.F., Medeiros D.H., Galdino N.A., Condino-Neto A., Calich V.L., Loures F.V. Tolerogenic Plasmacytoid Dendritic Cells Control Paracoccidioides brasiliensis Infection by Inducting Regulatory T Cells in an IDO-Dependent Manner. PLoS Pathog. 2016;12:e1006115. doi: 10.1371/journal.ppat.1006115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006115</ArticleId><ArticleId IdType="pmc">PMC5215616</ArticleId><ArticleId IdType="pubmed">27992577</ArticleId></ArticleIdList></Reference><Reference><Citation>Joo H., Upchurch K., Zhang W., Ni L., Li D., Xue Y., Li X.H., Hori T., Zurawski S., Liu Y.J., et al. Opposing Roles of Dectin-1 Expressed on Human Plasmacytoid Dendritic Cells and Myeloid Dendritic Cells in Th2 Polarization. J. Immunol. 2015;195:1723–1731. doi: 10.4049/jimmunol.1402276.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1402276</ArticleId><ArticleId IdType="pmc">PMC4530104</ArticleId><ArticleId IdType="pubmed">26123355</ArticleId></ArticleIdList></Reference><Reference><Citation>Segura E., Albiston A.L., Wicks I.P., Chai S.Y., Villadangos J.A. Different cross-presentation pathways in steady-state and inflammatory dendritic cells. Proc. Natl. Acad. Sci. USA. 2009;106:20377–20381. doi: 10.1073/pnas.0910295106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0910295106</ArticleId><ArticleId IdType="pmc">PMC2787113</ArticleId><ArticleId IdType="pubmed">19918052</ArticleId></ArticleIdList></Reference><Reference><Citation>Embgenbroich M., Burgdorf S. Current Concepts of Antigen Cross-Presentation. Front. Immunol. 2018;9:1643. doi: 10.3389/fimmu.2018.01643.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01643</ArticleId><ArticleId IdType="pmc">PMC6054923</ArticleId><ArticleId IdType="pubmed">30061897</ArticleId></ArticleIdList></Reference><Reference><Citation>Bevan M.J. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 1976;143:1283–1288. doi: 10.1084/jem.143.5.1283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.143.5.1283</ArticleId><ArticleId IdType="pmc">PMC2190184</ArticleId><ArticleId IdType="pubmed">1083422</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J.S., Yang C.W., Wang D.W., Wu-Hsieh B.A. Dendritic cells cross-present exogenous fungal antigens to stimulate a protective CD8 T cell response in infection by Histoplasma capsulatum. J. Immunol. 2005;174:6282–6291. doi: 10.4049/jimmunol.174.10.6282.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.174.10.6282</ArticleId><ArticleId IdType="pubmed">15879127</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho A., De Luca A., Bozza S., Cunha C., D’Angelo C., Moretti S., Perruccio K., Iannitti R.G., Fallarino F., Pierini A., et al. TLR3 essentially promotes protective class I-restricted memory CD8+ T-cell responses to Aspergillus fumigatus in hematopoietic transplanted patients. Blood. 2012;119:967–977. doi: 10.1182/blood-2011-06-362582.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2011-06-362582</ArticleId><ArticleId IdType="pubmed">22147891</ArticleId></ArticleIdList></Reference><Reference><Citation>Backer R., van Leeuwen F., Kraal G., den Haan J.M. CD8- dendritic cells preferentially cross-present Saccharomyces cerevisiae antigens. Eur. J. Immunol. 2008;38:370–380. doi: 10.1002/eji.200737647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.200737647</ArticleId><ArticleId IdType="pubmed">18200498</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardner A., de Mingo Pulido A., Ruffell B. Dendritic Cells and Their Role in Immunotherapy. Front. Immunol. 2020;11:924. doi: 10.3389/fimmu.2020.00924.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00924</ArticleId><ArticleId IdType="pmc">PMC7253577</ArticleId><ArticleId IdType="pubmed">32508825</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogasawara M., Miyashita M., Yamagishi Y., Ota S. Phase I/II Pilot Study of Wilms’ Tumor 1 Peptide-Pulsed Dendritic Cell Vaccination Combined with Conventional Chemotherapy in Patients with Head and Neck Cancer. Ther. Apher. Dial. 2019;23:279–288. doi: 10.1111/1744-9987.12831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1744-9987.12831</ArticleId><ArticleId IdType="pubmed">31033141</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanyi J.L., George E. Personalized vaccination against ovarian cancer: What are the possibilities? Expert. Rev. Vaccines. 2018;17:955–958. doi: 10.1080/14760584.2018.1541743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14760584.2018.1541743</ArticleId><ArticleId IdType="pmc">PMC6592278</ArticleId><ArticleId IdType="pubmed">30362844</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenblatt J., Avivi I., Vasir B., Uhl L., Munshi N.C., Katz T., Dey B.R., Somaiya P., Mills H., Campigotto F., et al. Vaccination with dendritic cell/tumor fusions following autologous stem cell transplant induces immunologic and clinical responses in multiple myeloma patients. Clin. Cancer Res. 2013;19:3640–3648. doi: 10.1158/1078-0432.CCR-13-0282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-13-0282</ArticleId><ArticleId IdType="pmc">PMC3755905</ArticleId><ArticleId IdType="pubmed">23685836</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Tendeloo V.F., Van de Velde A., Van Driessche A., Cools N., Anguille S., Ladell K., Gostick E., Vermeulen K., Pieters K., Nijs G., et al. Induction of complete and molecular remissions in acute myeloid leukemia by Wilms’ tumor 1 antigen-targeted dendritic cell vaccination. Proc. Natl. Acad. Sci. USA. 2010;107:13824–13829. doi: 10.1073/pnas.1008051107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1008051107</ArticleId><ArticleId IdType="pmc">PMC2922237</ArticleId><ArticleId IdType="pubmed">20631300</ArticleId></ArticleIdList></Reference><Reference><Citation>Tel J., Aarntzen E.H., Baba T., Schreibelt G., Schulte B.M., Benitez-Ribas D., Boerman O.C., Croockewit S., Oyen W.J., van Rossum M., et al. Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients. Cancer Res. 2013;73:1063–1075. doi: 10.1158/0008-5472.CAN-12-2583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-12-2583</ArticleId><ArticleId IdType="pubmed">23345163</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheever M.A., Higano C.S. PROVENGE (Sipuleucel-T) in prostate cancer: The first FDA-approved therapeutic cancer vaccine. Clin. Cancer Res. 2011;17:3520–3526. doi: 10.1158/1078-0432.CCR-10-3126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-10-3126</ArticleId><ArticleId IdType="pubmed">21471425</ArticleId></ArticleIdList></Reference><Reference><Citation>Inacio M.M., Moreira A.L.E., Cruz-Leite V.R.M., Mattos K., Silva L.O.S., Venturini J., Ruiz O.H., Ribeiro-Dias F., Weber S.S., Soares C.M.A., et al. Fungal Vaccine Development: State of the Art and Perspectives Using Immunoinformatics. J. Fungi. 2023;9:633. doi: 10.3390/jof9060633.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jof9060633</ArticleId><ArticleId IdType="pmc">PMC10301004</ArticleId><ArticleId IdType="pubmed">37367569</ArticleId></ArticleIdList></Reference><Reference><Citation>Tacken P.J., Zeelenberg I.S., Cruz L.J., van Hout-Kuijer M.A., van de Glind G., Fokkink R.G., Lambeck A.J., Figdor C.G. Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity. Blood. 2011;118:6836–6844. doi: 10.1182/blood-2011-07-367615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2011-07-367615</ArticleId><ArticleId IdType="pubmed">21967977</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam J.S., Huang H., Levitz S.M. Effect of differential N-linked and O-linked mannosylation on recognition of fungal antigens by dendritic cells. PLoS ONE. 2007;2:e1009. doi: 10.1371/journal.pone.0001009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0001009</ArticleId><ArticleId IdType="pmc">PMC1995759</ArticleId><ArticleId IdType="pubmed">17925857</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H., Ostroff G.R., Lee C.K., Specht C.A., Levitz S.M. Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded beta-glucan particles. mBio. 2010;1:e00164-10. doi: 10.1128/mBio.00164-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00164-10</ArticleId><ArticleId IdType="pmc">PMC2925077</ArticleId><ArticleId IdType="pubmed">20802824</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter R.W., Thompson C., Reid D.M., Wong S.Y., Tough D.F. Preferential induction of CD4+ T cell responses through in vivo targeting of antigen to dendritic cell-associated C-type lectin-1. J. Immunol. 2006;177:2276–2284. doi: 10.4049/jimmunol.177.4.2276.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.177.4.2276</ArticleId><ArticleId IdType="pubmed">16887988</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta O., Masso-Silva J.A., Wang K., Rivera A. Host response to pulmonary fungal infections: A highlight on cell-driven immunity to Cryptococcus species and Aspergillus fumigatus. Curr. Pharmacol. Rep. 2017;3:335–345. doi: 10.1007/s40495-017-0111-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40495-017-0111-4</ArticleId><ArticleId IdType="pmc">PMC5804991</ArticleId><ArticleId IdType="pubmed">29430385</ArticleId></ArticleIdList></Reference><Reference><Citation>Aimanianda V., Bayry J., Bozza S., Kniemeyer O., Perruccio K., Elluru S.R., Clavaud C., Paris S., Brakhage A.A., Kaveri S.V., et al. Surface hydrophobin prevents immune recognition of airborne fungal spores. Nature. 2009;460:1117–1121. doi: 10.1038/nature08264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08264</ArticleId><ArticleId IdType="pubmed">19713928</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoenigl M., Seidel D., Sprute R., Cunha C., Oliverio M., Goldman G.H., Ibrahim A.S., Carvalho A. COVID-19-associated fungal infections. Nat. Microbiol. 2022;7:1127–1140. doi: 10.1038/s41564-022-01172-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-022-01172-2</ArticleId><ArticleId IdType="pmc">PMC9362108</ArticleId><ArticleId IdType="pubmed">35918423</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaller M.A., Diekema D.J. Rare and emerging opportunistic fungal pathogens: Concern for resistance beyond Candida albicans and Aspergillus fumigatus. J. Clin. Microbiol. 2004;42:4419–4431. doi: 10.1128/JCM.42.10.4419-4431.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.42.10.4419-4431.2004</ArticleId><ArticleId IdType="pmc">PMC522363</ArticleId><ArticleId IdType="pubmed">15472288</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera A., Lodge J., Xue C. Harnessing the Immune Response to Fungal Pathogens for Vaccine Development. Annu. Rev. Microbiol. 2022;76:703–726. doi: 10.1146/annurev-micro-041020-111511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-micro-041020-111511</ArticleId><ArticleId IdType="pubmed">35759871</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira L.V.N., Wang R., Specht C.A., Levitz S.M. Vaccines for human fungal diseases: Close but still a long way to go. NPJ Vaccines. 2021;6:33. doi: 10.1038/s41541-021-00294-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41541-021-00294-8</ArticleId><ArticleId IdType="pmc">PMC7930017</ArticleId><ArticleId IdType="pubmed">33658522</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozza S., Gaziano R., Lipford G.B., Montagnoli C., Bacci A., Di Francesco P., Kurup V.P., Wagner H., Romani L. Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants. Microbes Infect. 2002;4:1281–1290. doi: 10.1016/S1286-4579(02)00007-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1286-4579(02)00007-2</ArticleId><ArticleId IdType="pubmed">12443892</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozza S., Perruccio K., Montagnoli C., Gaziano R., Bellocchio S., Burchielli E., Nkwanyuo G., Pitzurra L., Velardi A., Romani L. A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation. Blood. 2003;102:3807–3814. doi: 10.1182/blood-2003-03-0748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2003-03-0748</ArticleId><ArticleId IdType="pubmed">12791648</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao C., Qu J., He L., Zhang Y., Wang J., Zhou H., Wang Y., Liu X. Dendritic cells transduced with an adenovirus vector encoding interleukin-12 are a potent vaccine for invasive pulmonary aspergillosis. Genes. Immun. 2005;6:103–114. doi: 10.1038/sj.gene.6364167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.gene.6364167</ArticleId><ArticleId IdType="pubmed">15674391</ArticleId></ArticleIdList></Reference><Reference><Citation>Perruccio K., Bozza S., Montagnoli C., Bellocchio S., Aversa F., Martelli M., Bistoni F., Velardi A., Romani L. Prospects for dendritic cell vaccination against fungal infections in hematopoietic transplantation. Blood Cells Mol. Dis. 2004;33:248–255. doi: 10.1016/j.bcmd.2004.08.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcmd.2004.08.011</ArticleId><ArticleId IdType="pubmed">15528139</ArticleId></ArticleIdList></Reference><Reference><Citation>Awasthi S. Dendritic cell-based vaccine against coccidioides infection. Ann. N. Y. Acad. Sci. 2007;1111:269–274. doi: 10.1196/annals.1406.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1406.013</ArticleId><ArticleId IdType="pubmed">17363430</ArticleId></ArticleIdList></Reference><Reference><Citation>Chechi J.L., da Costa F.A.C., Figueiredo J.M., de Souza C.M., Valdez A.F., Zamith-Miranda D., Camara A.C., Taborda C.P., Nosanchuk J.D. Vaccine development for pathogenic fungi: Current status and future directions. Expert. Rev. Vaccines. 2023;22:1136–1153. doi: 10.1080/14760584.2023.2279570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14760584.2023.2279570</ArticleId><ArticleId IdType="pubmed">37936254</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou G., Wei Y. World Health Organization’s first-ever release of a fungal priority pathogens list: A reply action proposal for the prevention and treatment of fungal pathogens. Eco-Environ. Health. 2023;2:43–44. doi: 10.1016/j.eehl.2023.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eehl.2023.04.003</ArticleId><ArticleId IdType="pmc">PMC10702882</ArticleId><ArticleId IdType="pubmed">38075289</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W., Li R.Y. Enlightenment of World Health Organization fungal priority pathogens list. Zhonghua Liu Xing Bing Xue Za Zhi. 2023;44:1984–1987. doi: 10.3760/cma.j.cn112338-20230701-00410.</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.cn112338-20230701-00410</ArticleId><ArticleId IdType="pubmed">38129157</ArticleId></ArticleIdList></Reference><Reference><Citation>Sondermeyer G.L., Lee L.A., Gilliss D., Vugia D.J. Coccidioidomycosis-Associated Deaths in California, 2000–2013. Public Health Rep. 2016;131:531–535. doi: 10.1177/0033354916662210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0033354916662210</ArticleId><ArticleId IdType="pmc">PMC4937113</ArticleId><ArticleId IdType="pubmed">27453596</ArticleId></ArticleIdList></Reference><Reference><Citation>Loh J.T., Lam K.P. Fungal infections: Immune defense, immunotherapies and vaccines. Adv. Drug Deliv. Rev. 2023;196:114775. doi: 10.1016/j.addr.2023.114775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2023.114775</ArticleId><ArticleId IdType="pubmed">36924530</ArticleId></ArticleIdList></Reference><Reference><Citation>Peyclit L., Yousfi H., Rolain J.M., Bittar F. Drug Repurposing in Medical Mycology: Identification of Compounds as Potential Antifungals to Overcome the Emergence of Multidrug-Resistant Fungi. Pharmaceuticals. 2021;14:488. doi: 10.3390/ph14050488.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph14050488</ArticleId><ArticleId IdType="pmc">PMC8161392</ArticleId><ArticleId IdType="pubmed">34065420</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicola A.M., Albuquerque P., Paes H.C., Fernandes L., Costa F.F., Kioshima E.S., Abadio A.K.R., Bocca A.L., Felipe M.S. Antifungal drugs: New insights in research &amp; development. Pharmacol. Ther. 2019;195:21–38. doi: 10.1016/j.pharmthera.2018.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2018.10.008</ArticleId><ArticleId IdType="pubmed">30347212</ArticleId></ArticleIdList></Reference><Reference><Citation>Awasthi S., Awasthi V., Magee D.M., Coalson J.J. Efficacy of antigen 2/proline-rich antigen cDNA-transfected dendritic cells in immunization of mice against Coccidioides posadasii. J. Immunol. 2005;175:3900–3906. doi: 10.4049/jimmunol.175.6.3900.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.175.6.3900</ArticleId><ArticleId IdType="pubmed">16148136</ArticleId></ArticleIdList></Reference><Reference><Citation>Awasthi S., Vilekar P., Conkleton A., Rahman N. Dendritic cell-based immunization induces Coccidioides Ag2/PRA-specific immune response. Vaccine. 2019;37:1685–1691. doi: 10.1016/j.vaccine.2019.01.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2019.01.034</ArticleId><ArticleId IdType="pubmed">30795939</ArticleId></ArticleIdList></Reference><Reference><Citation>Awasthi S. Intranasal Antifungal Vaccination Using DNA-Transfected Dendritic Cells. Methods Mol. Biol. 2017;1625:75–83. doi: 10.1007/978-1-4939-7104-6_6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-7104-6_6</ArticleId><ArticleId IdType="pubmed">28584984</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilekar P., Awasthi V., Lagisetty P., King C., Shankar N., Awasthi S. In vivo trafficking and immunostimulatory potential of an intranasally-administered primary dendritic cell-based vaccine. BMC Immunol. 2010;11:60. doi: 10.1186/1471-2172-11-60.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2172-11-60</ArticleId><ArticleId IdType="pmc">PMC3018378</ArticleId><ArticleId IdType="pubmed">21143974</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Silva L.B.R., Taborda C.P., Nosanchuk J.D. Advances in Fungal Peptide Vaccines. J. Fungi. 2020;6:119. doi: 10.3390/jof6030119.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jof6030119</ArticleId><ArticleId IdType="pmc">PMC7558412</ArticleId><ArticleId IdType="pubmed">32722452</ArticleId></ArticleIdList></Reference><Reference><Citation>Prado M., Silva M.B., Laurenti R., Travassos L.R., Taborda C.P. Mortality due to systemic mycoses as a primary cause of death or in association with AIDS in Brazil: A review from 1996 to 2006. Memórias Do Inst. Oswaldo Cruz. 2009;104:513–521. doi: 10.1590/S0074-02762009000300019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0074-02762009000300019</ArticleId><ArticleId IdType="pubmed">19547881</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira K.S., Bastos K.R., Russo M., Almeida S.R. Interaction between Paracoccidioides brasiliensis and pulmonary dendritic cells induces interleukin-10 production and toll-like receptor-2 expression: Possible mechanisms of susceptibility. J. Infect. Dis. 2007;196:1108–1115. doi: 10.1086/521369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/521369</ArticleId><ArticleId IdType="pubmed">17763336</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva L.B.R., Taira C.L., Cleare L.G., Martins M., Junqueira M., Nosanchuk J.D., Taborda C.P. Identification of Potentially Therapeutic Immunogenic Peptides from Paracoccidioides lutzii Species. Front. Immunol. 2021;12:670992. doi: 10.3389/fimmu.2021.670992.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.670992</ArticleId><ArticleId IdType="pmc">PMC8144467</ArticleId><ArticleId IdType="pubmed">34046037</ArticleId></ArticleIdList></Reference><Reference><Citation>Travassos L.R., Taborda C.P. Linear Epitopes of Paracoccidioides brasiliensis and Other Fungal Agents of Human Systemic Mycoses As Vaccine Candidates. Front. Immunol. 2017;8:224. doi: 10.3389/fimmu.2017.00224.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00224</ArticleId><ArticleId IdType="pmc">PMC5344917</ArticleId><ArticleId IdType="pubmed">28344577</ArticleId></ArticleIdList></Reference><Reference><Citation>Jannuzzi G.P., de Almeida J.R.F., Dos Santos S.S., de Almeida S.R., Ferreira K.S. Notch Signaling is Required for Dendritic Cell Maturation and T Cell Expansion in Paracoccidioidomycosis. Mycopathologia. 2018;183:739–749. doi: 10.1007/s11046-018-0276-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11046-018-0276-3</ArticleId><ArticleId IdType="pubmed">29911286</ArticleId></ArticleIdList></Reference><Reference><Citation>Travassos L.R., Taborda C.P. New advances in the development of a vaccine against paracoccidioidomycosis. Front. Microbiol. 2012;3:212. doi: 10.3389/fmicb.2012.00212.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2012.00212</ArticleId><ArticleId IdType="pmc">PMC3373149</ArticleId><ArticleId IdType="pubmed">22701452</ArticleId></ArticleIdList></Reference><Reference><Citation>Magalhaes A., Ferreira K.S., Almeida S.R., Nosanchuk J.D., Travassos L.R., Taborda C.P. Prophylactic and therapeutic vaccination using dendritic cells primed with peptide 10 derived from the 43-kilodalton glycoprotein of Paracoccidioides brasiliensis. Clin. Vaccine Immunol. 2012;19:23–29. doi: 10.1128/CVI.05414-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CVI.05414-11</ArticleId><ArticleId IdType="pmc">PMC3255948</ArticleId><ArticleId IdType="pubmed">22089247</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva L.B.R., Taira C.L., Dias L.S., Souza A.C.O., Nosanchuk J.D., Travassos L.R., Taborda C.P. Experimental Therapy of Paracoccidioidomycosis Using P10-Primed Monocyte-Derived Dendritic Cells Isolated From Infected Mice. Front. Microbiol. 2019;10:1727. doi: 10.3389/fmicb.2019.01727.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2019.01727</ArticleId><ArticleId IdType="pmc">PMC6685297</ArticleId><ArticleId IdType="pubmed">31417520</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva L.B.R., Dias L.S., Rittner G.M.G., Munoz J.E., Souza A.C.O., Nosanchuk J.D., Travassos L.R., Taborda C.P. Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis. Front. Microbiol. 2017;8:1057. doi: 10.3389/fmicb.2017.01057.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2017.01057</ArticleId><ArticleId IdType="pmc">PMC5469887</ArticleId><ArticleId IdType="pubmed">28659882</ArticleId></ArticleIdList></Reference><Reference><Citation>Lizarazo J., Escandon P., Agudelo C.I., Firacative C., Meyer W., Castaneda E. Retrospective study of the epidemiology and clinical manifestations of Cryptococcus gattii infections in Colombia from 1997–2011. PLoS Negl. Trop. Dis. 2014;8:e3272. doi: 10.1371/journal.pntd.0003272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0003272</ArticleId><ArticleId IdType="pmc">PMC4238989</ArticleId><ArticleId IdType="pubmed">25411779</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC) Emergence of Cryptococcus gattii—Pacific Northwest, 2004–2010. Morb. Mortal. Wkly. Rep. (MMWR) 2010;59:865–868.</Citation><ArticleIdList><ArticleId IdType="pubmed">20651641</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajasingham R., Govender N.P., Jordan A., Loyse A., Shroufi A., Denning D.W., Meya D.B., Chiller T.M., Boulware D.R. The global burden of HIV-associated cryptococcal infection in adults in 2020: A modelling analysis. Lancet Infect. Dis. 2022;22:1748–1755. doi: 10.1016/S1473-3099(22)00499-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00499-6</ArticleId><ArticleId IdType="pmc">PMC9701154</ArticleId><ArticleId IdType="pubmed">36049486</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith R.M., Mba-Jonas A., Tourdjman M., Schimek T., DeBess E., Marsden-Haug N., Harris J.R. Treatment and outcomes among patients with Cryptococcus gattii infections in the United States Pacific Northwest. PLoS ONE. 2014;9:e88875. doi: 10.1371/journal.pone.0088875.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0088875</ArticleId><ArticleId IdType="pmc">PMC3929541</ArticleId><ArticleId IdType="pubmed">24586423</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueno K., Kinjo Y., Okubo Y., Aki K., Urai M., Kaneko Y., Shimizu K., Wang D.N., Okawara A., Nara T., et al. Dendritic cell-based immunization ameliorates pulmonary infection with highly virulent Cryptococcus gattii. Infect. Immun. 2015;83:1577–1586. doi: 10.1128/IAI.02827-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.02827-14</ArticleId><ArticleId IdType="pmc">PMC4363414</ArticleId><ArticleId IdType="pubmed">25644007</ArticleId></ArticleIdList></Reference><Reference><Citation>Goughenour K.D., Nair A.S., Xu J., Olszewski M.A., Wozniak K.L. Dendritic Cells: Multifunctional Roles in Host Defenses to Cryptococcus Infections. J. Fungi. 2023;9:1050. doi: 10.3390/jof9111050.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jof9111050</ArticleId><ArticleId IdType="pmc">PMC10672120</ArticleId><ArticleId IdType="pubmed">37998856</ArticleId></ArticleIdList></Reference><Reference><Citation>Hole C.R., Wager C.M.L., Castro-Lopez N., Campuzano A., Cai H., Wozniak K.L., Wang Y., Wormley F.L., Jr. Induction of memory-like dendritic cell responses in vivo. Nat. Commun. 2019;10:2955. doi: 10.1038/s41467-019-10486-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-10486-5</ArticleId><ArticleId IdType="pmc">PMC6609631</ArticleId><ArticleId IdType="pubmed">31273203</ArticleId></ArticleIdList></Reference><Reference><Citation>Nami S., Mohammadi R., Vakili M., Khezripour K., Mirzaei H., Morovati H. Fungal vaccines, mechanism of actions and immunology: A comprehensive review. Biomed. Pharmacother. 2019;109:333–344. doi: 10.1016/j.biopha.2018.10.075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2018.10.075</ArticleId><ArticleId IdType="pubmed">30399567</ArticleId></ArticleIdList></Reference><Reference><Citation>Caballero Van Dyke M.C., Wormley F.L., Jr. A Call to Arms: Quest for a Cryptococcal Vaccine. Trends Microbiol. 2018;26:436–446. doi: 10.1016/j.tim.2017.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2017.10.002</ArticleId><ArticleId IdType="pmc">PMC5910246</ArticleId><ArticleId IdType="pubmed">29103990</ArticleId></ArticleIdList></Reference><Reference><Citation>Wozniak K.L., Ravi S., Macias S., Young M.L., Olszewski M.A., Steele C., Wormley F.L. Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis. PLoS ONE. 2009;4:e6854. doi: 10.1371/journal.pone.0006854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0006854</ArticleId><ArticleId IdType="pmc">PMC2731172</ArticleId><ArticleId IdType="pubmed">19727388</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueno K., Urai M., Sadamoto S., Shinozaki M., Takatsuka S., Abe M., Otani Y., Yanagihara N., Shimizu K., Iwakura Y., et al. A dendritic cell-based systemic vaccine induces long-lived lung-resident memory Th17 cells and ameliorates pulmonary mycosis. Mucosal Immunol. 2019;12:265–276. doi: 10.1038/s41385-018-0094-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-018-0094-4</ArticleId><ArticleId IdType="pubmed">30279512</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzo J., Chaze T., Miranda K., Roberson R.W., Gorgette O., Nimrichter L., Matondo M., Latge J.P., Beauvais A., Rodrigues M.L. Characterization of Extracellular Vesicles Produced by Aspergillus fumigatus Protoplasts. mSphere. 2020;5:e00476-20. doi: 10.1128/msphere.00476-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/msphere.00476-20</ArticleId><ArticleId IdType="pmc">PMC7426166</ArticleId><ArticleId IdType="pubmed">32817450</ArticleId></ArticleIdList></Reference><Reference><Citation>Marina C.L., Burgel P.H., Agostinho D.P., Zamith-Miranda D., Las-Casas L.O., Tavares A.H., Nosanchuk J.D., Bocca A.L. Nutritional Conditions Modulate C. neoformans Extracellular Vesicles’ Capacity to Elicit Host Immune Response. Microorganisms. 2020;8:1815. doi: 10.3390/microorganisms8111815.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms8111815</ArticleId><ArticleId IdType="pmc">PMC7698703</ArticleId><ArticleId IdType="pubmed">33217920</ArticleId></ArticleIdList></Reference><Reference><Citation>Joffe L.S., Nimrichter L., Rodrigues M.L., Del Poeta M. Potential Roles of Fungal Extracellular Vesicles during Infection. mSphere. 2016;1:e00099-16. doi: 10.1128/mSphere.00099-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mSphere.00099-16</ArticleId><ArticleId IdType="pmc">PMC4933989</ArticleId><ArticleId IdType="pubmed">27390779</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandbrink J.B., Shattock R.J. RNA Vaccines: A Suitable Platform for Tackling Emerging Pandemics? Front. Immunol. 2020;11:608460. doi: 10.3389/fimmu.2020.608460.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.608460</ArticleId><ArticleId IdType="pmc">PMC7783390</ArticleId><ArticleId IdType="pubmed">33414790</ArticleId></ArticleIdList></Reference><Reference><Citation>Oda Y., Kumagai Y., Kanai M., Iwama Y., Okura I., Minamida T., Yagi Y., Kurosawa T., Greener B., Zhang Y., et al. Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: A double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial. Lancet Infect. Dis. 2024;24:351–360. doi: 10.1016/S1473-3099(23)00650-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00650-3</ArticleId><ArticleId IdType="pubmed">38141632</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>